Iron and Long COVID: Imbalances and Inflammatory Strain

Iron dysregulation has emerged as one of the more compelling and treatable threads running through Long COVID research. A 2024 paper in Nature Immunology described alterations in iron homeostasis and dysregulated red blood cell production as identifiable correlates of persistent symptoms after acute COVID-19, framing them as potentially “druggable” targets.¹ The picture that has taken shape over the past few years is not simply one of too much or too little iron, but of iron being shuttled into the wrong compartments at the wrong times, feeding inflammation while starving the cells that need it most.

What Happens to Iron During and After COVID

Your body tightly controls iron under normal circumstances. Most of it is locked inside hemoglobin in red blood cells, with smaller reserves stored in a protein called ferritin and modest amounts circulating in the blood bound to a transport protein. During a serious infection, the body deliberately pulls iron out of circulation and sequesters it in storage. This is an ancient defense strategy: many pathogens need iron to replicate, so starving the bloodstream of it slows them down. The problem is that SARS-CoV-2 can push this defensive response into overdrive, and in some people the system never fully resets after the acute infection clears.

The result is a paradox that frustrates both patients and doctors. Blood tests may show low circulating iron and even anemia, suggesting the person is iron-deficient. But at the same time, ferritin levels can be elevated, indicating that the body is hoarding iron rather than lacking it. This pattern, sometimes called functional iron deficiency, means iron is trapped in storage depots and unavailable to the tissues that depend on it, including muscles, the brain, and mitochondria throughout the body.

Ferritin as an Inflammatory Amplifier

Ferritin is often treated as a passive storage container in routine lab work, but researchers have increasingly recognized that it plays an active role in driving inflammation. In severe COVID-19, ferritin levels can spike to extraordinary levels, and a growing body of evidence suggests it is not merely responding to inflammation but amplifying it. One mechanistic review argued that ferritin likely operates as a proinflammatory cytokine in severe COVID-19, with its secretion triggered by other inflammatory signaling molecules, creating a self-reinforcing loop.² The authors compared this to the runaway immune activation seen in macrophage activation syndrome, a condition where the immune system essentially turns on the body’s own tissues.

What makes this relevant to Long COVID specifically, rather than just acute illness, is that ferritin levels do not always normalize once the virus is gone. Persistently elevated ferritin in the weeks and months after infection appears to track with ongoing symptoms, particularly fatigue. A study examining Long COVID patients who met criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) found that their serum ferritin was significantly higher compared to Long COVID patients without ME/CFS and to those with no lingering fatigue at all. The ME/CFS group had a median ferritin of about 193 micrograms per liter, roughly double that of the no-fatigue group.³ The association was especially pronounced in women.

This does not mean high ferritin causes ME/CFS or Long COVID fatigue in a simple, direct way. But it does suggest that persistent iron sequestration and the inflammatory state it reflects are meaningful parts of the symptom picture, not just incidental lab findings to file away.

Mitochondria and the Iron-Sulfur Connection

One of the places iron dysregulation hits hardest is inside mitochondria, the energy-producing compartments in nearly every cell. Mitochondria depend on iron-sulfur clusters, small molecular structures containing iron and sulfur atoms, to run the chemical chain reactions that generate cellular fuel. When iron handling goes haywire, these clusters can malfunction, and the downstream effect is an energy deficit that patients experience as crushing fatigue, exercise intolerance, and cognitive difficulty.

A 2025 review in Comprehensive Physiology noted that Long COVID symptoms may result from iron dysregulation and persistent oxidative stress caused by COVID-impaired mitochondrial function.⁴ The oxidative stress angle matters because misplaced iron is chemically reactive. Free iron that is not safely bound to proteins can catalyze the production of reactive oxygen species, which damage cell membranes, DNA, and the very mitochondria that were already struggling.

A bioinformatics study using network analysis to map Long COVID pathways independently flagged the CDGSH iron-sulfur domain-containing protein family as a critical regulator of the disease’s central mechanisms, including mitochondrial dysfunction, inflammatory clotting responses, and neuronal inflammation.⁵ These iron-sulfur proteins sit at a crossroads between iron handling, mitochondrial health, and inflammatory signaling, so their disruption could help explain why Long COVID symptoms span so many seemingly unrelated body systems.

Why “Just Take Iron” Is Not the Answer

A common instinct when hearing about iron problems is to reach for a supplement. For Long COVID patients, this can be genuinely counterproductive. The core issue for many is not that the body lacks iron overall but that iron is trapped in storage rather than being made available where it is needed. Dumping more iron into a system that is already hoarding it risks feeding the inflammatory fire without addressing the underlying distribution problem.

When iron sits in excess outside of its normal controlled pathways, it generates oxidative damage. In the context of an immune system that is already stuck in a hypervigilant state, additional iron can worsen tissue injury and potentially support lingering microbial threats. A study on post-COVID gut changes found that functional iron deficiency was associated with a significantly increased risk of secondary fungal infections in the sinuses of elderly patients, with an odds ratio of about 2.1.⁶ The implication is that even when cells are starved for available iron, the excess stored elsewhere can create an environment that promotes opportunistic infections.

This is why a standard ferritin test alone can be misleading. A Long COVID patient with high ferritin might look “fine” on paper, or even iron-replete, when in reality their tissues are functionally starved. Clinicians who understand this paradox typically look at a fuller panel including transferrin saturation, soluble transferrin receptor levels, and markers of inflammation like C-reactive protein to distinguish true iron deficiency from the functional kind.

Sex Differences in Iron and COVID Outcomes

Iron metabolism differs meaningfully between men and women under normal conditions, and these differences appear to carry into COVID-related outcomes. A Mendelian randomization study, which uses genetic variation to estimate causal effects, found a suggestive trend among women: genetically predicted higher serum iron levels were associated with an increased risk of severe COVID-19, with an odds ratio of about 1.63, though the result did not quite reach conventional statistical significance. Higher transferrin saturation showed a similar tendency in women. The corresponding results for men were less pronounced and had wide confidence intervals that made direct comparison between sexes unreliable.⁷

These findings are preliminary and need replication, but they align with clinical observations that ferritin’s role as an inflammatory marker and driver appears more prominent in women with Long COVID. The study on ferritin and ME/CFS overlap noted the same pattern: the link between elevated ferritin and severe fatigue was especially strong in female patients.³ Given that women are disproportionately affected by Long COVID overall, iron handling differences deserve more research attention than they have received so far.

Therapeutic Approaches Being Explored

The recognition that iron imbalance contributes to Long COVID pathology has prompted interest in several therapeutic strategies, though none have progressed to large-scale clinical trials for Long COVID specifically. The approaches fall into roughly three categories: chelation to remove excess iron, targeted supplementation to correct genuine deficiency, and indirect strategies that address the upstream inflammation driving iron maldistribution.

Iron chelation therapy uses drugs that bind free or excess iron and help the body excrete it. Deferoxamine, a chelator used for decades in conditions involving iron overload, has been proposed as a potential early intervention to limit the inflammatory cascade in COVID-19, particularly in patients with diabetes who already tend toward iron dysregulation.⁸ The logic is straightforward: if excess free iron is feeding oxidative damage and amplifying inflammation, removing it should break the cycle. Clinical data on chelation for Long COVID specifically remains thin, and the treatment carries its own risks, including removing iron the body actually needs, so it is not something to try outside of medical supervision.

On the supplementation side, the picture is more nuanced than a blanket recommendation for or against iron pills. A case report described an elderly woman with chronic iron deficiency anemia and multiple other health conditions who was hospitalized for COVID-19 and successfully treated with intravenous ferric carboxymaltose, a form of iron that can be delivered quickly and efficiently. Her hemoglobin and iron stores were replenished, transferrin saturation normalized, and the treatment was well tolerated alongside her COVID-19 recovery.⁹ The key distinction is that this patient had genuine, pre-existing iron deficiency anemia, not the functional iron deficiency pattern more commonly seen in Long COVID. For patients with true depletion, replacing iron makes clear clinical sense. For those with the maldistribution pattern, intravenous iron could theoretically worsen inflammation.

This underscores why lab interpretation matters so much. The same symptom of fatigue can stem from genuinely low iron stores or from iron trapped in the wrong places, and the treatments for those two problems are close to opposite.

The Gut, Probiotics, and Iron Absorption

COVID-19 frequently disrupts the gut, altering the microbiome in ways that persist well beyond the acute infection. This matters for iron because the gut is where dietary iron is absorbed, and the efficiency of that absorption depends heavily on the local bacterial population and on hepcidin, the liver hormone that acts as the master regulator of iron availability. When inflammation is high, hepcidin levels rise, which effectively shuts down iron absorption from the gut and locks existing iron into storage cells. The result is the functional deficiency pattern discussed earlier, even when dietary iron intake is adequate.

Probiotic supplementation has attracted attention as a way to address this indirectly. Certain probiotic strains appear to enhance iron bioavailability through anti-inflammatory effects that suppress hepcidin. Animal studies using multispecies probiotic formulas showed improved iron bioavailability, and a study in anemic preschool children found that iron-fortified milk combined with Lactobacillus acidophilus raised hemoglobin levels significantly more than iron-fortified milk alone.¹⁰ The proposed mechanism is that probiotics dampen the inflammatory signals that drive hepcidin up, allowing the gut to absorb iron normally again.

Whether this translates into meaningful benefit for Long COVID patients has not been tested in a rigorous trial. But the logic chain is plausible: if gut dysbiosis after COVID keeps hepcidin elevated, and probiotics can bring it back down, then restoring normal gut flora could help unlock the iron that is currently trapped in storage. This would be a gentler, less risky approach than chelation or iron infusion, though probably slower and more modest in effect.

What Standard Blood Work Misses

One of the more frustrating aspects of Long COVID for patients is the experience of feeling terrible while routine blood tests come back “normal.” Iron status is a prime example of where standard testing falls short. A basic metabolic panel typically does not include iron studies, and even when iron is checked, a single ferritin value can be deeply misleading in the context of chronic inflammation.

Ferritin is what is known as an acute-phase reactant, meaning it rises during any inflammatory process, independent of actual iron stores. A Long COVID patient with a ferritin of 300 micrograms per liter might be interpreted as having more than enough iron, when in reality the elevated reading is a marker of inflammation and the iron it represents is locked away and unusable. The same patient might simultaneously have low transferrin saturation and low serum iron, suggesting functional starvation at the tissue level.

Clinicians experienced with post-infectious syndromes tend to order a broader panel that includes serum iron, ferritin, transferrin saturation, total iron-binding capacity, and ideally soluble transferrin receptor levels. The ratio between ferritin and other markers paints a much more accurate picture of whether iron is genuinely deficient, genuinely excessive, or simply stuck in the wrong compartment. Some researchers have also proposed using the ferritin-to-transferrin ratio as a screening tool for the inflammatory iron-trapping pattern, though this has not been formally validated for Long COVID.

How Long COVID Iron Problems Overlap with ME/CFS

The overlap between Long COVID and ME/CFS has been noted since the early months of the pandemic, and iron dysregulation is one of the biological threads connecting the two. ME/CFS predated COVID by decades, and patients with that condition have long reported symptoms consistent with impaired iron utilization: profound fatigue, post-exertional malaise, cognitive dysfunction, and poor exercise tolerance. The fact that Long COVID patients who develop ME/CFS-pattern illness have significantly higher ferritin than those who recover more fully suggests a shared underlying mechanism.³

This connection is more than academic. ME/CFS has historically been under-researched and frequently dismissed by clinicians. The influx of Long COVID patients with similar symptoms has brought new funding and attention to mechanisms that might underlie both conditions, iron handling among them. If iron maldistribution proves to be a shared driver, treatments developed for one condition could benefit the other. The Nature Immunology team that described iron homeostasis alterations as potentially druggable in Long COVID explicitly framed their findings in terms of treatable correlates, meaning patterns that can be identified with existing lab tests and addressed with available therapies.¹

Practical Considerations for Patients

If you are dealing with Long COVID and suspect iron may be part of the picture, the single most useful step is getting a comprehensive iron panel rather than relying on ferritin alone. Ask for serum iron, ferritin, transferrin saturation, and total iron-binding capacity at minimum. Bring the full panel results to a clinician who understands the functional iron deficiency pattern, because interpretation requires looking at the numbers together rather than in isolation.

Avoid self-treating with iron supplements without lab guidance. If your ferritin is elevated in the context of ongoing inflammation, supplemental iron could worsen your symptoms. If your ferritin is genuinely low alongside low serum iron and low transferrin saturation, supplementation may be appropriate, but the form and route matter. Oral iron is poorly absorbed when hepcidin is elevated, which is common during active inflammation, so intravenous iron may be more effective in certain situations but requires medical administration.

Dietary strategies are lower risk and worth considering as a complement to medical care. An anti-inflammatory diet that includes iron-rich foods alongside vitamin C, which enhances iron absorption, addresses both sides of the equation. Fermented foods and probiotics may help restore gut health and normalize hepcidin signaling over time, potentially improving natural iron absorption.¹⁰ None of this substitutes for proper testing and medical guidance, but it gives patients something actionable while researchers continue to work out the details of more targeted interventions.